Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Waldmann

Showing results (31-40 of 442) with videos related to

Pageof 45
Sort By:
Nature|December 23, 1976
Evidence for the inactivation of precursor B cells in high dose unresponsivenessC Desaymard, H Waldmann
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2001
An enzyme-labile safety catch linker for synthesis on a soluble polymeric supportU Grether, H Waldmann
International Archives of Allergy and Immunology|October 20, 2001
Approaching tolerance in transplantationH Waldmann, S Cobbold
Bone Marrow Transplantation|March 1, 1996
Recent results using CAMPATH-1 antibodies to control GVHD and graft rejectionG Hale, H Waldmann
European Journal of Immunology|July 1, 1984
Allosuppression: evidence for the involvement of both "noncytotoxic" and cytotoxic T cellsR Zamoyska, H Waldmann
Trends in Pharmacological Sciences|May 1, 1993
The use of monoclonal antibodies to achieve immunological toleranceH Waldmann, S Cobbold
Bone Marrow Transplantation|May 1, 1994
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseasesG Hale, H Waldmann
Immunology Today|June 1, 1993
The use of monoclonal antibodies to achieve immunological toleranceH Waldmann, S Cobbold
Springer Seminars in Immunopathology|May 1, 1980
How many T cells help one B cell?H Waldmann, J Phillips
Immunology|July 1, 1974
T cell-dependent mediator in the immune response. II. Physical and biological propertiesH Waldmann, A Munro
Pageof 45

Showing results (31-40 of 442) with videos related to

Sort By:
Pageof 45
Nature|December 23, 1976
Evidence for the inactivation of precursor B cells in high dose unresponsivenessC Desaymard, H Waldmann
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2001
An enzyme-labile safety catch linker for synthesis on a soluble polymeric supportU Grether, H Waldmann
International Archives of Allergy and Immunology|October 20, 2001
Approaching tolerance in transplantationH Waldmann, S Cobbold
Bone Marrow Transplantation|March 1, 1996
Recent results using CAMPATH-1 antibodies to control GVHD and graft rejectionG Hale, H Waldmann
European Journal of Immunology|July 1, 1984
Allosuppression: evidence for the involvement of both "noncytotoxic" and cytotoxic T cellsR Zamoyska, H Waldmann
Trends in Pharmacological Sciences|May 1, 1993
The use of monoclonal antibodies to achieve immunological toleranceH Waldmann, S Cobbold
Bone Marrow Transplantation|May 1, 1994
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseasesG Hale, H Waldmann
Immunology Today|June 1, 1993
The use of monoclonal antibodies to achieve immunological toleranceH Waldmann, S Cobbold
Springer Seminars in Immunopathology|May 1, 1980
How many T cells help one B cell?H Waldmann, J Phillips
Immunology|July 1, 1974
T cell-dependent mediator in the immune response. II. Physical and biological propertiesH Waldmann, A Munro
Pageof 45